|
|
||||||||
1 Cardiovascular Research Institute and Department of Medical Physiology, Texas A&M University System Health Science Center, and 2 Department of Animal Science, Texas A&M University, College Station, Texas 77843-1114
Vascular abnormalities, including altered angiogenesis, are major factors contributing to the morbidity and mortality of diabetes. We hypothesized that impaired angiogenesis in diabetes results from decreased tetrahydrobiopterin (BH4)-dependent synthesis of nitric oxide (NO) by endothelial cells (EC). To test this hypothesis, we utilized EC from spontaneously diabetic BB (BBd) and nondiabetes-prone BB (BBn) rats to investigate the link between BH4 and EC proliferation. There were significant decreases in the proliferation rate and expression of proliferating cell nuclear antigen in BBd versus BBn EC, with no evidence of apoptosis in either group. Sepiapterin (a precursor of BH4 via the salvage pathway) increased BH4 synthesis and enhanced proliferation of BBd EC. The stimulating effect of sepiapterin on EC proliferation was attenuated by NG-monomethyl-L-arginine, a NO synthase inhibitor. Reducing BH4 concentrations in BBn EC caused a decrease in proliferation, which was attenuated by a long-acting NO donor. Our results suggest that BH4 levels regulate proliferation of normal EC and that a BH4 deficiency impairs NO-dependent proliferation of BBd EC.
angiogenesis; nitric oxide; biopterin; diabetes mellitus; wound healing
This article has been cited by other articles:
![]() |
I. A. Ionova, J. Vasquez-Vivar, J. Whitsett, A. Herrnreiter, M. Medhora, B. C. Cooley, and G. M. Pieper Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytes Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2178 - H2187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Michaelis, R. Michaelis, T. Suhan, H. Schmidt, A. Mohamed, H. W. Doerr, and J. Cinatl Jr. Ribavirin inhibits angiogenesis by tetrahydrobiopterin depletion FASEB J, January 1, 2007; 21(1): 81 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Emanueli, G. Graiani, M. B. Salis, S. Gadau, E. Desortes, and P. Madeddu Prophylactic Gene Therapy With Human Tissue Kallikrein Ameliorates Limb Ischemia Recovery in Type 1 Diabetic Mice Diabetes, April 1, 2004; 53(4): 1096 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, C. J. Meininger, K. A. Kelly, J. R. Hawker Jr., S. M. Morris Jr., and G. Wu Activities of arginase I and II are limiting for endothelial cell proliferation Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R64 - R69. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |